Novavax Announces Positive Preclinical Data for Combination Influenza and COVID-19 Vaccine Candidate

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/24/2026

1. QCOM
2. FDX
3. CBRS
4. USO
5. SPY
6. MU
7. KBH
8. HTZ
9. HON
10. JPM

Go back to Novavax Announces Positive Preclinical Data for Combination Influenza and COVID-19 Vaccine Candidate

JPMorgan Downgrades Novavax (NVAX) to Neutral

May 12, 2021 5:45 AM EDT

JPMorgan analyst Eric Joseph downgraded Novavax (NASDAQ: NVAX) from Overweight to Neutral with a price target of $161.00 (from $285.00).

The analyst comments "We are rated Neutral on NVAX shares. While topline UK phase 3 results reported to date have shown compelling efficacy, amid a series of clinical,... More